Is Our Microbiome a Predictor of Cardiac Risk

StatusSuspended
PhaseNot specified
Started

Free. We email you which fields changed when ClinicalTrials.gov updates this record.

Track this trial
View on ClinicalTrials.gov ↗

Record History

See every version on ClinicalTrials.gov ↗

  1. Trial status changed: Enrolling by Invitation → Suspended Sponsor's reason: Reorganizing study personnel and funding
    • Primary and study completion pushed from Sep 2026 to Dec 2027
    • Eligibility criteria expanded, about 4 words
  2. Primary and study completion dates: Sep 2025 to Sep 2026
    • Trial status: Recruiting to Enrolling by Invitation
    • Site details revised
    v17
  3. Enrollment target: 500 to 700
    • Site contact updated
    v16
  4. Primary and study completion dates: Sep 2024 to Sep 2025
    • Site contact updated
    v15
  5. Primary and study completion dates: Sep 2023 to Sep 2024
    • Site contact updated
    • Eligibility criteria expanded, about 2 words
    v14
Show 12 earlier versionsHide 12 earlier versions
  1. Enrollment target: 200 to 500
    • Primary and study completion dates: Sep 2022 to Sep 2023
    v13
  2. Site contact updatedv12
  3. Primary and study completion dates: Sep 2021 to Sep 2022v11
  4. Primary and study completion dates: Sep 2020 to Sep 2021v10
  5. Primary and study completion dates: Sep 2019 to Sep 2020v9
  6. Primary and study completion dates: Sep 2017 to Sep 2019
    • Site contact updated
    v8
  7. Primary completion date: Oct 2016 to Sep 2017
    • Study completion date: Mar 2017 to Sep 2017
    v7
  8. Site contact updatedv6
  9. Re-verified, no change to tracked fieldsv5
  10. Enrollment target: 100 to 200v4 Show 5 more changesShow less
    • Primary completion date: Nov 2015 to Oct 2016
    • Study completion date: May 2016 to Mar 2017
    • Eligibility criteria expanded, about 28 words
    • Study description expanded, about 80 words
    • Site contact updated
  11. Re-verified, no change to tracked fieldsv3
  12. Eligibility criteria expanded, about 1 wordv2
  1. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
Mayo Clinic
1,025 trials monitored
See 131 trials at risk
Heart Disease
8,827 trials monitored
See 432 trials at risk
Coronary Artery Disease
1,625 trials monitored
See 71 trials at risk
The purpose of this study is to determine a relationship between a person's flora/bacteria in their gut (the intestinal microbiome) and their risk of cardiovascular disease. Investigators will look at inflammatory markers in the blood and also look at the genome of the bacteria in the gut.
Trial Details
NCT Number NCT02013284
Lead Sponsor Mayo Clinic
Conditions
(from sponsor)		 Coronary Artery Disease
Related terms Coronary Artery Disease
Enrollment 700 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov